Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03434379 |
|---|---|
| Brief Title: | A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave150) |
| First Submitted : | January 31, 2018 |
| First Submitted that Met QC Criteria : | February 9, 2018 |
| First Posted : | February 15, 2018 |
| Results First Submitted : | August 16, 2021 |
| Results First Posted with QC Comments : | September 16, 2021 |
| Results First Submitted that Met QC Criteria : | October 7, 2021 |
| Results First Posted : | November 5, 2021 |
| Last Update Submitted that Met QC Criteria : | November 22, 2022 |
| Last Update Posted : | November 25, 2022 |